(Calcalist) Hagar Ravet - Israeli medtech and biotech companies are working to find new solutions to the coronavirus challenge. Israeli-American RADLogics Inc. is a software analytics company that specializes in visual analysis of medical scans to detect early signs of lung cancer. Two months ago, RADLogics' products in China started revealing something small and patch-like in the lungs of patients, a phenomenon unique to coronavirus patients. It was also found in asymptomatic carriers. The company adjusted its products for the specific identification of coronavirus, and now it offers a new identification avenue that can provide results within seconds instead of hours. Tel Aviv-based Sight Diagnostics Ltd. developed a portable device that enables blood tests and blood counts with results in minutes rather than hours. Sheba Medical Center at Tel HaShomer announced it will use the device to treat patients in isolation. Biopharmaceutical company Kamada Ltd. is collecting blood and plasma from Israelis who have recovered from the virus, and using a purification process to achieve a specific concentration of antibodies for treating serious coronavirus cases. This is not a vaccine, but rather an expensive, one-off treatment for severe cases. Israel-based EarlySense Ltd. has developed a non-invasive patient-monitoring system, placed under the mattress, that takes a patient's vitals around the clock, 100 times a minute, to identify changes in a patient's condition. It can also be used to track asymptomatic carriers in home-quarantine.
2020-03-24 00:00:00Full ArticleBACK Visit the Daily Alert Archive